Predictive factors for sustained virological response after treatment with pegylated interferon α-2a and ribavirin in patients infected with HCV genotypes 2 and 3.
<h4>Background</h4>Previous trials have often defined genotype 2 and 3 patients as an "easy to treat" group and guidelines recommend similar management.<h4>Aims</h4>The present study looks for differences between the two genotypes and analyzes predictive factors for...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Public Library of Science (PLoS)
2014
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/7d1f2f83d9d84eda81a49ca51c12a914 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|